F32GM009940 (ANDREEFF, MICHAEL W)Jul 1, 1985 NIH DIRECTED MUTAGENESIS OF HPRT GENES IN CULTURED CELLS Role: Principal Investigator |
|
R01CA038980 (ANDREEFF, MICHAEL W)Jul 1, 1985 - Dec 31, 1988 NIH CELL BIOLOGY AND PHARMACOKINETICS OF LOW-DOSE ARA-C Role: Principal Investigator |
|
R01CA041305 (ANDREEFF, MICHAEL W)Apr 1, 1986 - Dec 31, 1990 NIH FUNCTION OF QUIESCENT CELLS IN PEDIATRIC LEUKEMIA Role: Principal Investigator |
|
R29HD022880 (ANDREEFF, MICHAEL W)May 1, 1987 - Apr 30, 1993 NIH MOLECULAR BIOLOGY OF T LYMPHOCYTE PROGENITOR CELLS Role: Principal Investigator |
|
S10RR007383 (ANDREEFF, MICHAEL W)Sep 30, 1991 - Sep 29, 1993 NIH GAMMACELL 40 SELF-CONTAINED IRRADIATOR Role: Principal Investigator |
|
R01CA057639 (ANDREEFF, MICHAEL W)Aug 17, 1992 - Jul 31, 1996 NIH CYTOKINE/CHEMOTHERAPY COMBINATIONS IN MYELOID LEUKEMIA Role: Principal Investigator |
|
R01CA062595 (ANDREEFF, MICHAEL W)Sep 1, 1993 - Aug 31, 1997 NIH FISH ANALYSIS OF LYMPHOMA Role: Principal Investigator |
|
R01HL051232 (ANDREEFF, MICHAEL W)Aug 1, 1994 - Jul 31, 1998 NIH GENE TRAP SCREEN APPROACH TO STEM CELL DEVELOPMENT Role: Principal Investigator |
|
R01DK048647 (ANDREEFF, MICHAEL W)Sep 30, 1994 - Aug 31, 1998 NIH GENETIC ANALYSIS OF STEM CELLS USING DIFFERENTIAL PCR Role: Principal Investigator |
|
P01CA055164 (ANDREEFF, MICHAEL W)May 27, 1997 - Sep 29, 2000 NIH THE THERAPY OF AML Role: Principal Investigator |
|
R03TW000930 (ANDREEFF, MICHAEL W)May 1, 1998 - Apr 30, 2003 NIH BCL2 AND P53 IN CYTO PROTEC OF AML CELLS FROM APOPTOSIS Role: Principal Investigator |
|
R01CA089346 (ANDREEFF, MICHAEL W)Sep 1, 2002 - Aug 31, 2006 NIH Anti-Leukemic Activity of the Novel Triterpeniod CDDO Role: Principal Investigator |
|
R01FD003733 (ANDREEFF, MICHAEL)Sep 21, 2009 - Aug 31, 2016 NIH Plerixafor/G-CSF with Sorafenib for Acute Myelogenous Leukemia with FLT3-ITD Muta Role: Principal Investigator |
|
R21CA143805 (ANDREEFF, MICHAEL W)Apr 5, 2010 - Mar 31, 2014 NIH Combined inhibition of CXCR4 and FLT3-ITD signaling in acute myeloid leukemia Role: Principal Investigator |
|
R01FD006118 (ANDREEFF, MICHAEL)Sep 1, 2019 - Jun 30, 2024 NIH Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014) Role: Principal Investigator |